Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 205613 / DOSAGE - AEROSOL, FOAM;RECTAL - 2MG/ACTUATION
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUDESONIDE(UNII: Q3OKS62Q6X) (BUDESONIDE - UNII:Q3OKS62Q6X) | BUDESONIDE | 28mg |
Inactive Ingredients
| Ingredient Name | Oceanside Pharmaceuticals | Salix Pharmaceuticals, Inc. |
|---|---|---|
| BUTANE(6LV4FOR43R) | ||
| CETOSTEARYL ALCOHOL(2DMT128M1S) | ||
| CETYL ALCOHOL(936JST6JCN) | ||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||
| EDETATE DISODIUM(7FLD91C86K) | ||
| ISOBUTANE(BXR49TP611) | ||
| POLYSORBATE 60(CAL22UVI4M) | ||
| PROPANE(T75W9911L6) | ||
| PROPYLENE GLYCOL(6DC9Q167V3) | ||
| STEARETH-10(FD0913P475) | ||
| WATER(059QF0KO0R) |
